home / stock / ardx / ardx quote
Last: | $5.28 |
---|---|
Change Percent: | 17.44% |
Open: | $6.25 |
Close: | $5.28 |
High: | $6.4699 |
Low: | $5.07 |
Volume: | 22,525,977 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.28 | $6.25 | $5.28 | $6.4699 | $5.07 | 22,525,977 | 07-02-2024 |
$7.57 | $7.47 | $7.57 | $8.06 | $7.39 | 7,043,493 | 07-01-2024 |
$7.41 | $6.59 | $7.41 | $7.44 | $6.552 | 11,926,729 | 06-28-2024 |
$6.5 | $6.1 | $6.5 | $6.52 | $5.99 | 2,889,291 | 06-27-2024 |
$6.11 | $6.01 | $6.11 | $6.165 | $5.905 | 3,570,188 | 06-26-2024 |
$6.02 | $6.23 | $6.02 | $6.29 | $5.94 | 4,049,316 | 06-25-2024 |
$6.25 | $6.17 | $6.25 | $6.315 | $6.06 | 3,600,473 | 06-24-2024 |
$6.16 | $5.93 | $6.16 | $6.16 | $5.9 | 6,854,293 | 06-21-2024 |
$5.89 | $5.97 | $5.89 | $5.9799 | $5.76 | 3,907,550 | 06-20-2024 |
$5.95 | $6.27 | $5.95 | $6.33 | $5.865 | 4,956,663 | 06-19-2024 |
$5.95 | $6.27 | $5.95 | $6.33 | $5.865 | 4,956,663 | 06-18-2024 |
$6.29 | $6.31 | $6.29 | $6.41 | $6.26 | 2,771,015 | 06-17-2024 |
$6.35 | $6.39 | $6.35 | $6.53 | $6.26 | 4,074,383 | 06-14-2024 |
$6.49 | $6.67 | $6.49 | $6.75 | $6.4 | 3,142,727 | 06-13-2024 |
$6.69 | $6.82 | $6.69 | $6.91 | $6.625 | 2,365,365 | 06-12-2024 |
$6.63 | $6.49 | $6.63 | $6.69 | $6.345 | 3,705,844 | 06-11-2024 |
$6.46 | $6.4 | $6.46 | $6.48 | $6.25 | 5,463,649 | 06-10-2024 |
$6.45 | $6.725 | $6.45 | $6.725 | $6.44 | 3,038,714 | 06-07-2024 |
$6.74 | $7.08 | $6.74 | $7.12 | $6.7 | 3,727,278 | 06-06-2024 |
$7.13 | $6.91 | $7.13 | $7.155 | $6.815 | 3,586,718 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
17.44%Change Percent:
Ardelyx Inc. Company Name:
ARDX Stock Symbol:
NASDAQ Market:
Ardelyx Inc. Website:
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...